Study underway to evaluate anemia risk in infants with HDFN
A global non-interventional registry study aims to evaluate the risk of anemia in infants who may be at risk of HDFN.
A global non-interventional registry study aims to evaluate the risk of anemia in infants who may be at risk of HDFN.
An extensive literature review outlined the current recommendations for hemolytic disease of the fetus and newborn diagnosis and management.
An upcoming study will analyze the prevalence, risk factors and clinical characteristics of neonatal anemia, a common complication of HDFN.
A recent case report described a patient who presented with an uncommon case of HDFN caused by anti-LU1 (anti-Luᵃ) alloantibodies.
Machine learning is a form of AI that may be able to help doctors predict jaundice risk.
Extending delivery at or beyond 34 weeks and performing an IUT around that time could be beneficial in pregnancies complicated with HDFN.
A study found that neonatal hyperbilirubinemia, a common complication of HDFN, is linked to early weight loss during the neonatal period.
The clinical characteristics and outcomes of pregnancies at risk of HDFN in Sweden, Finland and Denmark, were analyzed in a study.
Researchers found a low rate of HDFN prophylaxis with Rh immunoglobulin (RHIG) among Rh-negative pregnant women in India.
Results showed that patients who developed jaundice within 24 hours after birth were less likely to have severe jaundice.